Monte Rosa Therapeutics Stock Net Asset
| GLUE Stock | USD 5.65 0.05 0.89% |
Monte Rosa Therapeutics fundamentals help investors to digest information that contributes to Monte Rosa's financial success or failures. It also enables traders to predict the movement of Monte Stock. The fundamental analysis module provides a way to measure Monte Rosa's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Monte Rosa stock.
Monte | Net Asset |
Monte Rosa Therapeutics Company Net Asset Analysis
Monte Rosa's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Monte Rosa Net Asset | 303.75 M |
Most of Monte Rosa's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Monte Rosa Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Monte Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Monte Rosa is extremely important. It helps to project a fair market value of Monte Stock properly, considering its historical fundamentals such as Net Asset. Since Monte Rosa's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Monte Rosa's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Monte Rosa's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Monte Total Assets
Total Assets |
|
Based on the recorded statements, Monte Rosa Therapeutics has a Net Asset of 303.75 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Monte Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Monte Rosa's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Monte Rosa could also be used in its relative valuation, which is a method of valuing Monte Rosa by comparing valuation metrics of similar companies.Monte Rosa is currently under evaluation in net asset category among related companies.
Monte Rosa Institutional Holders
Institutional Holdings refers to the ownership stake in Monte Rosa that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Monte Rosa's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Monte Rosa's value.| Shares | Geode Capital Management, Llc | 2023-12-31 | 687.7 K | State Street Corporation | 2023-12-31 | 573.4 K | Casdin Capital, Llc | 2023-12-31 | 510.9 K | Northern Trust Corp | 2023-12-31 | 284.9 K | Charles Schwab Investment Management Inc | 2023-12-31 | 245.6 K | Exoduspoint Capital Management, Lp | 2023-12-31 | 229.8 K | Td Asset Management Inc | 2023-12-31 | 193.2 K | Candriam Luxembourg S.c.a. | 2023-12-31 | 135 K | Renaissance Technologies Corp | 2023-12-31 | 105.2 K | Nea Management Company, Llc | 2023-12-31 | 7.7 M | Fmr Inc | 2023-12-31 | 5.5 M |
Monte Fundamentals
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.28 | ||||
| Current Valuation | 96.91 M | ||||
| Shares Outstanding | 50.15 M | ||||
| Shares Owned By Insiders | 0.86 % | ||||
| Shares Owned By Institutions | 98.16 % | ||||
| Number Of Shares Shorted | 1.87 M | ||||
| Price To Earning | 1.91 X | ||||
| Price To Book | 2.01 X | ||||
| EBITDA | (137.09 M) | ||||
| Net Income | (135.35 M) | ||||
| Cash And Equivalents | 294.14 M | ||||
| Cash Per Share | 6.32 X | ||||
| Total Debt | 46.04 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 20.11 X | ||||
| Book Value Per Share | 3.58 X | ||||
| Cash Flow From Operations | (43.8 M) | ||||
| Short Ratio | 11.37 X | ||||
| Earnings Per Share | (2.63) X | ||||
| Target Price | 16.5 | ||||
| Number Of Employees | 133 | ||||
| Beta | 1.45 | ||||
| Market Capitalization | 284.34 M | ||||
| Total Asset | 303.75 M | ||||
| Retained Earnings | (365.89 M) | ||||
| Working Capital | 189.62 M | ||||
| Net Asset | 303.75 M |
About Monte Rosa Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Monte Rosa Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Monte Rosa using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Monte Rosa Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Monte Rosa Piotroski F Score and Monte Rosa Altman Z Score analysis. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Monte Stock analysis
When running Monte Rosa's price analysis, check to measure Monte Rosa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Monte Rosa is operating at the current time. Most of Monte Rosa's value examination focuses on studying past and present price action to predict the probability of Monte Rosa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Monte Rosa's price. Additionally, you may evaluate how the addition of Monte Rosa to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Monte Rosa's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monte Rosa. If investors know Monte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monte Rosa listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.63) | Return On Assets (0.28) | Return On Equity (0.60) |
The market value of Monte Rosa Therapeutics is measured differently than its book value, which is the value of Monte that is recorded on the company's balance sheet. Investors also form their own opinion of Monte Rosa's value that differs from its market value or its book value, called intrinsic value, which is Monte Rosa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monte Rosa's market value can be influenced by many factors that don't directly affect Monte Rosa's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monte Rosa's value and its price as these two are different measures arrived at by different means. Investors typically determine if Monte Rosa is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monte Rosa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.